Virios Therapeutics (VIRI) Earnings Date, Estimates & Call Transcripts → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free VIRI Stock Alerts $0.41 +0.02 (+5.17%) (As of 05/15/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 9) -$0.07 Beat By $0.01 Consensus EPS (May. 9) -$0.08 Read Call TranscriptListen to Call Get Virios Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for VIRI and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVIRI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VIRI Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Manward PressAmazon's betting big on this unknown AI companyAmazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company Virios Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.08)($0.08)($0.08)Q2 20241($0.07)($0.07)($0.07)Q3 20241($0.07)($0.07)($0.07)Q4 20241($0.07)($0.07)($0.07)FY 20244($0.29)($0.29)($0.29)Q1 20251($0.05)($0.05)($0.05)Q2 20251($0.05)($0.05)($0.05)Q3 20251($0.05)($0.05)($0.05)Q4 20251($0.06)($0.06)($0.06)FY 20254($0.21)($0.21)($0.21)VIRI Earnings Date and InformationVirios Therapeutics last issued its earnings data on May 9th, 2024. The reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.01. Virios Therapeutics has generated ($0.27) earnings per share over the last year (($0.27) diluted earnings per share). Earnings for Virios Therapeutics are expected to decrease in the coming year, from ($0.27) to ($0.30) per share. Virios Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Virios Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 5/9/2024Q1 2024($0.08)($0.07)+$0.01($0.07)-- 2/29/2024Q4 2023($0.09)($0.06)+$0.03($0.06)--11/13/2023Q3 2023($0.10)($0.06)+$0.04($0.06)-- 8/10/2023Q2 2023($0.07)($0.08)($0.01)($0.08)-- 5/11/2023Q1 2023-($0.08)($0.08)($0.08)--3/14/2023Q4 2022($0.16)($0.11)+$0.05($0.11)-- Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Q3 2022($0.49)($0.28)+$0.21($0.28)--8/11/2022Q2 2022($0.51)($0.44)+$0.07($0.44)-- 5/12/2022Q1 2022($0.54)($0.48)+$0.06($0.48)--3/17/2022Q4 2021($0.52)($0.54)($0.02)($0.54)-- 11/11/2021Q3 2021($0.70)($0.49)+$0.21($0.49)-- 8/12/2021Q2 2021($0.56)($0.51)+$0.05($0.51)-- Virios Therapeutics Earnings - Frequently Asked Questions When is Virios Therapeutics's earnings date? Virios Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on VIRI's earnings history. Did Virios Therapeutics beat their earnings estimates last quarter? In the previous quarter, Virios Therapeutics (NASDAQ:VIRI) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.01. Learn more on analysts' earnings estimate vs. VIRI's actual earnings. How can I listen to Virios Therapeutics's earnings conference call? The conference call for Virios Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Virios Therapeutics's conference call transcript? The conference call transcript for Virios Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Virios Therapeutics generate each year? Virios Therapeutics (NASDAQ:VIRI) has a recorded net income of -$5.30 million. VIRI has generated -$0.27 earnings per share over the last four quarters. What is Virios Therapeutics's EPS forecast for next year? Virios Therapeutics's earnings are expected to decrease from ($0.27) per share to ($0.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CVKD Earnings Results TRVN Earnings Results NCNA Earnings Results BFRI Earnings Results CYCN Earnings Results VCNX Earnings Results EFTR Earnings Results HEPA Earnings Results KTTA Earnings Results CANF Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:VIRI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
